Phase III studies are often multi national and multi center trials based on results from the product’s earlier Phase I and II clinical trials. They are mostly required to register a drug with regulatory bodies in order to acquire marketing approval.
Our site netowrk, partners and specifically our role in the ONE Clinical Trial Alliance allows us to engage in these trials. Furthermore our regulaotry professionals are able to select optimal candidates for quick recruitment. To make sure your trial is adequately attuned to your drug approval strategy, we provide advice from experienced drug development specialists.
We offer a thorough selection of potential sites through feasibility, based on our preliminary assessment and by former experience. Our risk monitoring approach combines on-site, online and central monitoring, to control risks making sure monitoring resources are adequatly employed.